SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-126963
Filing Date
2023-12-18
Accepted
2023-12-18 17:18:50
Documents
1
Group Members
MERIDIAN VENTURE PARTNERS II, CO.MERIDIAN VENTURE PARTNERS II, L.P.ROBERT E. BROWN, JR.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2333161d1_sc13da.htm SC 13D/A 77826
  Complete submission text file 0001104659-23-126963.txt   79753
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60689 | Film No.: 231494754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087
Business Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 610-254-2999
Meridian Venture Partners II GP, L.P. (Filed by) CIK: 0001580170 (see all company filings)

IRS No.: 233030799 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13D/A